Brief: Tonix Pharmaceuticals Expects Topline Data For Tnx-1300 In Q3 2025, TNX-1500 In Q1 2025
08/01/2025 12:56
Jan 8 (Reuters) - Tonix Pharmaceuticals Holding Corp
TNXP.O :
* TONIX PHARMACEUTICALS HOLDING CORP - EXPECTS TOPLINE DATA
FOR
TNX-1300 IN Q3 2025, TNX-1500 IN Q1 2025
Source text: https://shorturl.at/8efwq
Further company coverage: TNXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview